BVF Insider Trading Activity and SEC Form 4 Filings
BVF insider trading summary
No open-market insider purchases or sales of BIOVAIL Corp (BVF) have been reported on SEC Form 4 in the past 12 months.
Latest BVF insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 20, 2010 | Mark Andrew Durham | SVP, HR & Shared Services | Sell | $1.3M (60,000 @ $22.26) |
| Aug 9, 2010 | Christine Mayer | SVP, BTA Pharmaceuticals, Inc. | Sell | $46K (2,000 @ $22.90) |
| Aug 9, 2010 | Christine Mayer | SVP, BTA Pharmaceuticals, Inc. | Sell | $46K (2,000 @ $22.95) |
| Aug 9, 2010 | Christine Mayer | SVP, BTA Pharmaceuticals, Inc. | Sell | $92K (4,000 @ $22.92) |
| Aug 9, 2010 | Christine Mayer | SVP, BTA Pharmaceuticals, Inc. | Sell | $46K (2,000 @ $22.93) |
| Aug 9, 2010 | Christine Mayer | SVP, BTA Pharmaceuticals, Inc. | Sell | $183K (8,000 @ $22.91) |
| Aug 9, 2010 | Christine Mayer | SVP, BTA Pharmaceuticals, Inc. | Sell | $46K (2,000 @ $22.96) |
| Jun 1, 2010 | Douglas John Paul Squires | Director | Sell | $1.1M (75,033 @ $14.77) |
| May 11, 2010 | Michel Chouinard | CCO, Biovail Labs. Intl SRL | Sell | $134K (7,886 @ $16.95) |
| May 11, 2010 | Michel Chouinard | CCO, Biovail Labs. Intl SRL | Sell | $20K (1,200 @ $16.96) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.